加西诺酸通过激活Nrf2依赖的细胞酶来增强对结肠炎的炎症解决
Ibrahim Isot1, Seong Hoon Kim2, Tugce Demirel-Yalciner3
1Department of Biochemistry, Faculty of Medicine, Marmara University, Istanbul, Türkiye; Institute of Health Sciences, Marmara University, Istanbul, Türkiye.
Free radical biology & medicine
|May 31, 2025
概括
加西诺酸 (GA) 增强了细胞的清除,帮助炎症解决. 这种植物代谢物通过促进细胞清理机制,显示出治疗不解决炎症疾病的治疗潜力.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症解决对于预防慢性疾病至关重要.
- 炎症解消中断可能导致缩和纤维化.
- 细胞化,或细胞化的细胞清除,是解决炎症的关键.
研究的目的:
- 为了研究加西诺酸 (GA) 在增强血细胞分裂和炎症解决中的作用.
- 阐明GA的亲解决效应背后的机制.
- 评估GA在炎症状况中的治疗潜力.
主要方法:
- 在体外研究中,使用巨细胞评估细胞瘤标记物 (MerTK,LRP-1,TIM4) 和专门的亲溶解脂质介质 (SPM).
- 在体内研究使用硫酸 (DSS) 诱导的大肠炎小鼠模型.
- 在巨细胞中进行Nrf2沉默和HO-1抑制实验.
主要成果:
- 在巨细胞中增强GA的效细胞化,涉及MerTK,LRP-1,TIM4和SPM,如利素A4和溶解素E1.
- 在DSS诱导的大肠炎模型中,GA治疗减少了炎症和退行性症状,与增加的结肠细胞增多相关.
- Nrf2通路和HO-1活性与GA的增强细胞质和促进溶解的作用有关.
结论:
- 加西诺酸充当了细胞增强剂.
- 亚甘氨酸显示出作为治疗不解决炎症疾病的治疗剂的潜力.
- 甲基的亲解决效应部分通过Nrf2通路和应激反应进行调解.
更多相关视频
相关概念视频
Inflammatory Response
8.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
8.6K
Inflammatory Bowel Disease IV: Pharmacological Management
205
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
205
Gastritis-II: Pathophysiology
614
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
614
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278


